Bruker Corporation has announced a global settlement with 10x Genomics, effectively ending all ongoing litigation between the two companies. The settlement includes global patent cross license agreements, leading to the dismissal of multiple lawsuits and administrative proceedings in various countries, including the United States and Germany. This resolution allows both companies to focus on their contributions to the scientific community without the distraction of legal disputes.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bruker Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250514837657) on May 14, 2025, and is solely responsible for the information contained therein.